{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:59:53Z","timestamp":1781114393777,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jhep.2012.09.014","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T16:32:59Z","timestamp":1348677179000},"page":"212-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States"],"prefix":"10.1016","volume":"58","author":[{"given":"Dwayne M.","family":"Baxa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish D.","family":"Thekdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Golembieski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant V.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kizy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Shetron-Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jovanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi J.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Snow-Lampart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katyna","family":"Borroto-Esoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.09.014_b0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2893.2006.00787.x","article-title":"Chronic hepatitis B: current epidemiology in the Americas and implications for management","volume":"13","author":"Gish","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.09.014_b0010","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jhep.2012.09.014_b0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection","volume":"2","author":"Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2012.09.014_b0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/653622","article-title":"The prevalence of hepatitis B virus infection in the United States in the era of vaccination","volume":"202","author":"Wasley","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2012.09.014_b0025","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.09.014_b0030","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.09.014_b0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.193.7.847","article-title":"Kinetics of acute hepatitis B virus infection in humans","volume":"193","author":"Whalley","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2012.09.014_b0040","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1046\/j.1432-1033.2003.03650.x","article-title":"Fidelity of hepatitis B virus polymerase","volume":"270","author":"Park","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jhep.2012.09.014_b0045","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1440-1746.2009.06118.x","article-title":"Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains","volume":"25","author":"Hayashi","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.09.014_b0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3748\/wjg.15.753","article-title":"Hepatitis B virus mutations potentially conferring adefovir\/tenofovir resistance in treatment-naive patients","volume":"15","author":"Pastor","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.09.014_b0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2010.05.010","article-title":"Acute hepatitis B infection associated with drug-resistant hepatitis B virus","volume":"48","author":"Xu","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2012.09.014_b0060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/viro.1994.1247","article-title":"The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring Hepatitis B virus variants","volume":"200","author":"Laskus","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2012.09.014_b0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.21290","article-title":"Evolution of multi-drug resistant hepatitis B virus during sequential therapy","volume":"44","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.09.014_b0070","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/01.aids.0000252059.85236.af","article-title":"Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance","volume":"20","author":"Truong","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2012.09.014_b0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SMJ.0b013e3181fcd75b","article-title":"Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005\u20132009","volume":"104","author":"Youmans","year":"2011","journal-title":"South Med J"},{"key":"10.1016\/j.jhep.2012.09.014_b0080","unstructured":"New DHHS guidelines for antiretroviral therapy. AIDS Alert 2010;25:21\u201324."},{"key":"10.1016\/j.jhep.2012.09.014_b0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcv.2008.11.010","article-title":"Genotyping of acute HBV isolates from England, 1997\u20132001","volume":"44","author":"Sloan","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2012.09.014_b0090","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/AAC.01318-07","article-title":"Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA","volume":"52","author":"Margeridon","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2012.09.014_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7150\/ijms.2.8","article-title":"Advances in molecular diagnosis of HBV infection and drug resistance","volume":"2","author":"Sablon","year":"2005","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jhep.2012.09.014_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jhep.2008.08.020","article-title":"Sensitivity and accuracy of an updated line probe assay (HBV DR v. 3) in detecting mutations associated with hepatitis B antiviral resistance","volume":"50","author":"Degertekin","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.09.014_b0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.antiviral.2008.09.004","article-title":"Dynamics of hepatitis B virus resistance to entecavir in a nucleoside\/nucleotide-naive patient","volume":"81","author":"Guo","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2012.09.014_b0110","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1128\/jvi.68.12.8102-8110.1994","article-title":"Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen","volume":"68","author":"Okamoto","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.09.014_b0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/hep.1840220605","article-title":"Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations","volume":"22","author":"Rodriguez-Frias","year":"1995","journal-title":"Hepatology"},{"issue":"Pt. 9","key":"10.1016\/j.jhep.2012.09.014_b0120","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/0022-1317-81-9-2267","article-title":"An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam","volume":"81","author":"Hannoun","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2012.09.014_b0125","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1093\/nar\/gkr451","article-title":"Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome","volume":"39","author":"Homs","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2012.09.014_b0130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/597808","article-title":"Ultra-deep pyrosequencing of hepatitis B virus quasi-species from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients","volume":"199","author":"Margeridon-Thermet","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2012.09.014_b0135","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/JVI.02011-08","article-title":"Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen","volume":"83","author":"Solmone","year":"2009","journal-title":"J Virol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:09:07Z","timestamp":1781111347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812007453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0168827812007453"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.09.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2012.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}